ドゥピルマブは,鼻のポリープを伴う慢性鼻炎を伴う重度のエオシノフィル性喘息の患者に報告された咳を軽減し,生活の質を改善します
Carlo Lombardi1, Alvise Berti2,3, Francesco Menzella4
1Departmental Unit of Allergology & Pneumology, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.
Drugs in context
|September 4, 2025
まとめ
重度のエオシノフィル性喘息 (SEA) と鼻のポリープを伴う慢性鼻炎 (CRSwNP) の患者で,デュピルマブは慢性咳 (CC) と生活の質を大幅に改善しました. この研究は,ドピルマブ
科学分野:
- 呼吸器医学
- 臨床免疫学
- 薬理学について
背景:
- 慢性咳 (CC) は重度のエオシノフィル性喘息 (SEA) と鼻のポリープを伴う慢性鼻炎 (CRSwNP) の重要な症状である.
- 現在の喘息のガイドラインは,咳の治療を十分に扱っていません.
- これらの患者集団におけるドピルマブの治療的役割については,さらなる調査が必要である.
研究 の 目的:
- 慢性咳の軽減におけるドゥピルマブの有効性を評価する.
- SEAおよびCRSwNP患者の生活の質に対するドピルマブの影響を評価する.
- ダピルマブが治療可能な特徴として咳の治療の可能性を調査する.
主な方法:
- CCとSEA,CRSwNP,またはその両方を持つ67人の患者の潜在的な含有.
- ドピルマブを6ヶ月投与する.
- 激しい咳の視覚アナログスケール (SC-VAS) と,レスター咳アンケート (LCQ) による生活品質の評価
主要な成果:
- ドピルマブ治療の6ヶ月後,SC- VASとLCQスコアの両方の有意な改善が観察されました (p<0. 001).
- 臨床的に有意義な改善は,SC- VASの73%とLCQの82%で報告されました.
- デュピルマブは,SEA,CRSwNP,およびSEAとCRSwNPの組み合わせを含むすべての疾患サブセットにおいて顕著な有効性を示した.
結論:
- ドゥピルマブは慢性咳を大幅に軽減し,CRSwNPの患者でもそれなしでもSEAの患者の生活の質を向上させます.
- これらの発見は,これらの状態における慢性咳の管理のためのドピルマブの検討を支持する.
- ドゥピルマブは,呼吸器疾患の独特で治療可能な特徴として,咳の治療に希望を示しています.
関連する概念動画
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
425
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
425
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446
COPD: Management Using Bronchodilators and Corticosteroids
300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300
Antiasthma Drugs: Leukotriene Modifiers
453
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
453
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
573
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
573


